Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer

  1. Bardia, A.
  2. Tolaney, S.M.
  3. Punie, K.
  4. Loirat, D.
  5. Oliveira, M.
  6. Kalinsky, K.
  7. Zelnak, A.
  8. Aftimos, P.
  9. Dalenc, F.
  10. Sardesai, S.
  11. Hamilton, E.
  12. Sharma, P.
  13. Recalde, S.
  14. Gil, E.C.
  15. Traina, T.
  16. O'Shaughnessy, J.
  17. Cortes, J.
  18. Tsai, M.
  19. Vahdat, L.
  20. Diéras, V.
  21. Carey, L.A.
  22. Rugo, H.S.
  23. Goldenberg, D.M.
  24. Hong, Q.
  25. Olivo, M.
  26. Itri, L.M.
  27. Hurvitz, S.A.
  28. Montrer des auteurs +
Revue:
Annals of Oncology

ISSN: 1569-8041,  0923-7534

Année de publication: 2021

Volumen: 32

Número: 9

Pages: 1148-1156

Type: Article

DOI: 10.1016/J.ANNONC.2021.06.002 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus